A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/LY3650150 in Participants with Chronic Rhinosinusitis with Nasal Polyps on Background Intranasal Corticosteroids

Protocol No
OTO-ELILILLY-J2T-MC-KGBU
Staff Member
David M Poetker
Phase
III
Summary

This project is being done to determine if an experimental drug called lebrikizumab is a safe and effective treatment for people with chronic rhinosinusitis with nasal polyps (CRSwNP).
Objective
Lebrikizumab vs. Placebo w/ Steroids in CRSwNP
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Ear, Nose and Throat
ClinicalTrials.gov
https://www.clinicaltrials.gov/study/NCT06338995